HBV infection and familial aggregation of liver cancer: An analysis of case-control family study

Cancer Causes and Control

Volumn 15, Issue 8, 2004, Pages 845-850

  Gao, Yanhui ^a   Jiang, Qingwu ^a   Zhou, Xuefu ^b   Ding, Baoguo ^b   Wang, Ruhong ^b   Zhao, Genming ^a   Chen, Yue ^c  

^a FUDAN UNIVERSITY   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

case control family study; familial aggregation; generalized estimating equation; HBV infection; liver cancer

Indexed keywords

ARTICLE; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOMA; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PEDIGREE; RISK FACTORS;

EID: 5044233765     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000043435.59195.3c     Document Type: Article

References (40)

1. Dominguez MH, Gaytan GS (2001) Hepatocellular carcinoma: an update. Ultrastruct Pathol 25: 497-516.
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF (2001) International trends and patterns of primary liver cancer. Int J Cancer 94: 290-296.
3. Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11: 369-376.
4. Wang JS, Huang T, Su J et al. (2001) Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 10: 143-146.
5. Zhang JY, Dai M, Wang X (1998) A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 27: 574-578.
6. Chen G, Yu SZ, Wei, GR, Chen GC, Xu XY, Huang YH (1996) Studies on microcystin contents in different drinking water in highly endemic area of liver cancer. Chin J Prev Med 30: 6-9.
7. Yu SZ, Zhao N, Zi XL et al. (2001) The relationship between cyanotoxin (Microcystin, MC) in pond ditch water and primary liver cancer in China. Chin J Oncol 23: 96-99.
8. Yu MC, Yuan JM, Govindarajan S, Ross RK (2000) Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14: 703-709.
9. Yu MW, Chang HC, Liaw YF et al. (2000) Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92: 1159-1164.
10. Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12: S294-S308.
11. Donato F, Gelatti U, Chiesa R, Albertini A (1999) A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Cancer Causes and Control 10: 417-421.
12. Alberts SR, Lanier AP, McMahon BJ et al. (1991) Clustering of hepatocellular carcinoma in Alaska Native families. Genet Epidemiol 8: 127-139.
13. Santantonio T, Jung MC, Pastore G, Angarano G, Gunther S, Will H (1997) Familial clustering of HBV pre-C and pre-S mutants. J Hepat 26: 221-227.
14. Szmuness W, Harley EJ, Prince AM (1975) Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 270: 293-304.
15. Szmuness W, Prince AM, Hirsch RL, Brotman B (1973) Familial clustering of hepatitis B infection. N Engl J Med 289:1162-1166.
16. Society of Liver Cancer, CACA (2000) The standard of Primary hepatocellular carcinoma. Chin J Hepatol 8: 135.
17. Liang KY, Zeger SL and Qaqish B (1992) Multivariate regression analyses for categorical data (with discuss). J R Stat Soc Ser B 54: 3-40.
18. Qaqish, BF and Liang, KY (1992) Marginal models for correlated binary responses with multiple classes and multiple levels of nesting. Biometrics 48: 939-950.
19. SAS OnlineDoc, Version 8. SAS/STAT User's Guide.
20. Carey V, Zeger SL (1993) Modelling multivariate binary data with alternating logistic regressions. Biometrika 80: 517-526.
21. Teo EK, Fock KM (2001) Hepatocellular carcinoma: an Asian perspective. Dig Dis 19: 263-268.
22. Monto A, Wright TL (2001) The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28: 441-449.
23. Safary A, Beck J (2000) Vaccination against hepatitis B: current challenges for Asian countries and future directions. J Gastroenterol Hepatol 15: 396-401.
24. Chang MH, Chen DS (1999) Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 13: 511-517.
25. Tsai JF, Chuang LY, Jeng JE et al. (2001) Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer 84: 709-713.
26. Kuper HE, Tzonou A, Kaklamani E et al. (2000) Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control 11: 171-175.
27. Chiesa R, Donato F, Tagger A et al. (2000) Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 9: 213-216.
28. Omer RE, Van't Veer P, Kadaru AM et al. (2001) The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. Trans R Soc Trop Med Hyg 95: 487-491.
29. Mori M, Hara M, Wada I et al. (2000) Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 151: 131-139.
30. Beasley RP, Trepo C, Stevens CE, Szmuness W (1977) The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105: 94-98.
31. Tai DI, Lo SK, Kuo CH et al. (2002) Replication of hepatitis B in HbsAg-positive siblings. J Viral Hepat 9: 272-279.
32. Khoury MJ, Beaty TH, Liang KY (1988) Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127: 674-83.
33. Guo SW (2000) Familial aggregation of environmental risk factors and familial aggregation of disease. Am J Epidemiol 151: 1121-1131.
34. Kountouras J, Lygidakis NJ (2000) New epidemiological data on liver oncogenesis. Hepato Gastroenterol 47: 855-861.
35. Tai DI, Changchien CS, Hung CS, Chen CJ (1999) Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma. Am J Trop Med Hyg 61: 716-719.
36. Shen FM, Lee MK, Gong HM, Cai XQ, King MC (1991) Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet 49: 88-93.
37. Yang P, Buetow KH, Lustbader ED (1990) Evidence for a major locus modifying risk for primary hepatocellular carcinoma. Am J Hum Genet 47(Suppl. A25).
38. Yu MW, Chiu YH, Chiang YC et al. (1999) Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carinoma:independent and interactive effects. Am J Epidemiol 149: 621-629.
39. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ (1999) A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency and cigarette smoking in hepatitis B carriers. Hepatology 29: 697-702.
40. Chen CJ, Yu MW, Liaw YF et al. (1996) Chronic hepatitis B carriers with null genotypes of glutathione S-trasferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 59: 128-134.